Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1982 | 1 |
1996 | 2 |
2002 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Müllerian inhibiting substance as a model for the transforming growth factor-beta family: development of new treatment strategies.
Semin Pediatr Surg. 1996 Aug;5(3):182-90.
Semin Pediatr Surg. 1996.
PMID: 8858765
Review.
Developmental expression of a candidate müllerian inhibiting substance type II receptor.
Teixeira J, He WW, Shah PC, Morikawa N, Lee MM, Catlin EA, Hudson PL, Wing J, Maclaughlin DT, Donahoe PK.
Teixeira J, et al.
Endocrinology. 1996 Jan;137(1):160-5. doi: 10.1210/endo.137.1.8536608.
Endocrinology. 1996.
PMID: 8536608
Item in Clipboard
Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Laurich VM, Trbovich AM, O'Neill FH, Houk CP, Sluss PM, Payne AH, Donahoe PK, Teixeira J.
Laurich VM, et al.
Endocrinology. 2002 Sep;143(9):3351-60. doi: 10.1210/en.2001-211352.
Endocrinology. 2002.
PMID: 12193547
Item in Clipboard
Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
Fuller AF Jr, Guy S, Budzik GP, Donahoe PK.
Fuller AF Jr, et al.
J Clin Endocrinol Metab. 1982 May;54(5):1051-5. doi: 10.1210/jcem-54-5-1051.
J Clin Endocrinol Metab. 1982.
PMID: 6895900
Item in Clipboard
Cite
Cite